Employment and work disability in systemic lupus erythematosus: a systematic review.

scientific article published on 19 January 2009

Employment and work disability in systemic lupus erythematosus: a systematic review. is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P356DOI10.1093/RHEUMATOLOGY/KEN477
P698PubMed publication ID19153144

P50authorJanet PopeQ48742471
P2093author name stringKim Baker
P2860cites workQuantifying heterogeneity in a meta-analysisQ27860672
Meta-analysis in clinical trialsQ27860779
Work dynamics among persons with systemic lupus erythematosusQ33871651
Systemic lupus erythematosus in a multiethnic US cohort LUMINA (XLI): factors predictive of self-reported work disabilityQ35638310
Measurement of fatigue in systemic lupus erythematosus: a systematic reviewQ37020357
Validation of the systemic lupus erythematosus activity questionnaire in a large observational cohortQ37137321
Time perspective predicts the progression of permanent organ damage in patients with systemic lupus erythematosusQ40573631
Outcome of neuropsychiatric systemic lupus erythematosus within a defined Swedish population: increased morbidity but low mortalityQ44795825
Adherence with advice and prescriptions in SLE is mostly good, but better follow up is needed: a study with a questionnaireQ50146708
Total costs and predictors of costs in patients with systemic lupus erythematosus.Q50669701
Rheumatological manifestations, organ damage and autoimmunity in hereditary C2 deficiency.Q50803898
Functional disability and health-related quality of life in South Africans with rheumatoid arthritis and systemic lupus erythematosus.Q51920376
P433issue3
P921main subjectsystemic lupus erythematosusQ1485
disabilityQ12131
systematic reviewQ1504425
P304page(s)281-284
P577publication date2009-01-19
P1433published inRheumatologyQ7320492
P1476titleEmployment and work disability in systemic lupus erythematosus: a systematic review
P478volume48

Reverse relations

cites work (P2860)
Q35816153Assessment of the Economic Impact of Belimumab for the Treatment of Systemic Lupus Erythematosus in the Italian Setting: A Cost-Effectiveness Analysis
Q38968818Burden of lupus on work: Issues in the employment of individuals with lupus
Q38416827Capturing complexity in work disability research: application of system dynamics modeling methodology
Q47193610Cognitive functioning in systemic lupus erythematosus: a meta-analysis
Q48618855Comparison of neuropsychological impairment and vocational outcomes in systemic lupus erythematosus and multiple sclerosis patients
Q55214707Cultural and quality-of-life considerations when administering corticosteroids as a therapeutic strategy for African American women living with systemic lupus erythematosus.
Q30248866Current Perspectives on Arthroplasty in Systemic Lupus Erythematosus: Rates, Outcomes, and Adverse Events
Q34267149Data quality challenges in systemic lupus erythematosus trials: how can this be optimized?
Q55234314Definition of NPSLE: Does the ACR Nomenclature Still Hold?
Q35156880Determinants of work disability in patients with systemic sclerosis: a longitudinal study of the GENISOS cohort
Q46496211Ethnicity in systemic lupus erythematosus (SLE): its influence on susceptibility and outcomes
Q34424649Exploring lifetime occupational exposure and SLE flare: a patient-focussed pilot study
Q36411744Filling the gaps in SARDs research: collection and linkage of administrative health data and self-reported survey data for a general population-based cohort of individuals with and without diagnoses of systemic autoimmune rheumatic disease (SARDs) f
Q33708268Health-related quality of life and employment among persons with systemic lupus erythematosus
Q47650187Impact of cognitive impairment, depression, disease activity, and disease damage on quality of life in women with systemic lupus erythematosus
Q88062932Impact of early systemic lupus erythematosus on work disability-results from the Finnish nationwide register 2000-2007
Q35243135Impact of obesity on functioning among women with systemic lupus erythematosus
Q48192370Impact of systemic lupus erythematosus on burden of illness and work productivity in the United States
Q35998043Influence of Education on Disease Activity and Damage in Systemic Lupus Erythematosus: Data From the 1000 Canadian Faces of Lupus
Q41544586Job Accommodations Availability and Utilization Among People With Lupus: An Examination of Workplace Activity Limitations and Work Context Factors
Q34234020Linguistic Validation of the LupusQoL for the Assessment of Quality of Life in Iranian Patients with Systemic Lupus Erythematosus.
Q57461365Long-term impact of belimumab on health-related quality of life and fatigue in patients with systemic lupus erythematosus: 6 years of treatment
Q35686616Longitudinal study of the impact of incident organ manifestations and increased disease activity on work loss among persons with systemic lupus erythematosus
Q45183938Lupus and community-based social work
Q39257920Markers for work disability in anti-neutrophil cytoplasmic antibody-associated vasculitis.
Q37922765Neuropsychiatric manifestations in systemic lupus erythematosus: epidemiology, pathophysiology and management
Q34351248Optimal management of fatigue in patients with systemic lupus erythematosus: a systematic review
Q47292875Predictors of disability in a childhood-onset systemic lupus erythematosus cohort: results from the CARRA Legacy Registry
Q47724375Productivity Losses and Costs in the Less-Common Systemic Autoimmune Rheumatic Diseases.
Q39287162Psychosocial impact of mast cell disorders: Pilot investigation of a rare and understudied disease
Q55006497Self-care agency in systemic lupus erythematosus and its associated factors: a cross-sectional study.
Q38858733Socioeconomic Predictors of Incident Depression in Systemic Lupus Erythematosus.
Q50848358Systemic lupus erythematosus.
Q36112610The Lived Experience of Lupus Flares: Features, Triggers, and Management in an Australian Female Cohort
Q37800303The economic burden of systemic lupus erythematosus in Asia: the current state
Q38936647The global burden of SLE: prevalence, health disparities and socioeconomic impact
Q37978906The socioeconomic burden of systemic lupus erythematosus: state-of-the-art and prospects.
Q37309687The substantial burden of systemic lupus erythematosus on the productivity and careers of patients: a European patient-driven online survey
Q40957928Total cost and cost predictors in systemic lupus erythematosus - 8-years follow-up of a Swedish inception cohort
Q58785147Transition and transfer of the patient with paediatric-onset lupus: a practical approach for paediatric and adult rheumatology practices
Q39150632Unmet Needs in the Pathogenesis and Treatment of Systemic Lupus Erythematosus.
Q35848834Using Wii Fit to reduce fatigue among African American women with systemic lupus erythematosus: a pilot study
Q37985709What do we know about self-reported fatigue in systemic lupus erythematosus?
Q44362369Work disability in systemic lupus erythematosus is prevalent and associated with socio-demographic and disease related factors
Q35008185Work disability, lost productivity and associated risk factors in patients diagnosed with systemic lupus erythematosus
Q44382733Work factors are associated with workplace activity limitations in systemic lupus erythematosus
Q92526957Work participation, mobility and foot symptoms in people with systemic lupus erythematosus: findings of a UK national survey

Search more.